Thrivent Financial for Lutherans’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-58,951
Closed -$521K 2612
2025
Q3
$521K Buy
+58,951
New +$420K ﹤0.01% 2062
2025
Q2
Sell
-28,748
Closed -$190K 2521
2025
Q1
$190K Hold
28,748
﹤0.01% 2324
2024
Q4
$250K Buy
+28,748
New +$414K ﹤0.01% 2453
2023
Q4
Sell
-39,465
Closed -$359K 2522
2023
Q3
$359K Sell
39,465
-26,711
-40% -$271K ﹤0.01% 2249
2023
Q2
$700K Sell
66,176
-10,848
-14% -$128K ﹤0.01% 2029
2023
Q1
$942K Hold
77,024
﹤0.01% 1822
2022
Q4
$956K Sell
77,024
-64,201
-45% -$933K ﹤0.01% 1758
2022
Q3
$1.93M Buy
141,225
+51,738
+58% +$798K 0.01% 1241
2022
Q2
$1.64M Buy
+89,487
New +$1.29M ﹤0.01% 1370
2021
Q3
Sell
-14,300
Closed -$298K 2498
2021
Q2
$298K Sell
14,300
-30,827
-68% -$765K ﹤0.01% 2332
2021
Q1
$1.27M Sell
45,127
-31,053
-41% -$982K ﹤0.01% 1724
2020
Q4
$2.49M Buy
+76,180
New +$2.68M 0.01% 1180

Other funds holding KURA